Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product
| Brand name | MONTELUKAST SODIUM |
| Generic name | MONTELUKAST SODIUM |
| Active ingredient(s) | MONTELUKAST |
| Distributed by / for | Macleods Pharma USA, Inc. Plainsboro, NJ |
| NDC | 33342-111-10 |
| Full product label | Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India NDC 33342-111-10 |
| Recalling firm | Macleods Pharma Usa Inc |
| Distribution | Nationwide within the United States |
| Quantity | 10680 units |
| Recall initiated | 2020-01-20 |
| Report date | 2020-02-05 |
| Recall completed | 2021-04-26 |
| Recall number | D-0823-2020 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Plainsboro NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗